Roderic Espin
Barcelona, CT 08908, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 09, 2026
Exploring glucocorticoid receptor signalling in lymphangioleiomyomatosis.
Journal: ERJ open research
Published: September 22, 2025
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment.
Journal: NAR cancer
Published: October 17, 2024
DNA double-strand break-capturing nuclear envelope tubules drive DNA repair.
Journal: Nature structural & molecular biology
Published: March 09, 2024
PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients.
Journal: Molecular oncology
Published: September 15, 2023
Biological basis of extensive pleiotropy between blood traits and cancer risk.
Journal: Genome medicine
Published: August 11, 2023
Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function.
Journal: ERJ open research
Published: June 02, 2021
Modification of BRCA1-associated breast cancer risk by HMMR overexpression.
Journal: Nature communications
Published: May 20, 2021
Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue.
Journal: Molecular cancer research : MCR
Published: March 25, 2021
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
Journal: EMBO molecular medicine
Published: January 09, 2021
Last Updated: 09/26/2026